92 related articles for article (PubMed ID: 11496360)
1. Does a "false negative" MIBG scan predict a better outcome in neuroblastoma patients?
Chan GC; Leung YL; Shing MM; Luk CW; Ling SC; Lee AC
Med Pediatr Oncol; 2001 Aug; 37(2):155. PubMed ID: 11496360
[No Abstract] [Full Text] [Related]
2. Does a "false-negative" MIBG scan predict a better outcome in neuroblastoma patients?
Garaventa A
Med Pediatr Oncol; 2001 Oct; 37(4):418. PubMed ID: 11568913
[No Abstract] [Full Text] [Related]
3. False positive MIBG scan due to accessory spleen.
Granata C; Carlini C; Conte M; Claudiani F; Campus R; Rizzo A
Med Pediatr Oncol; 2001 Aug; 37(2):138-9. PubMed ID: 11496353
[No Abstract] [Full Text] [Related]
4. Positive MIBG scanning at the time of relapse in neuroblastoma which was MIBG negative at diagnosis.
Britton KE
Br J Radiol; 1997 Sep; 70(837):969. PubMed ID: 9486080
[No Abstract] [Full Text] [Related]
5. Positive MIBG scanning at the time of relapse in neuroblastoma which was MIBG negative at diagnosis.
Plowman PN
Br J Radiol; 1997 Sep; 70(837):969. PubMed ID: 9486081
[No Abstract] [Full Text] [Related]
6. 131I-MIBG in the diagnosis of primary and metastatic neuroblastoma.
El-Maghraby T
Gulf J Oncolog; 2007 Jul; (2):33-41. PubMed ID: 20084722
[TBL] [Abstract][Full Text] [Related]
7. False-positive MIBG scans with normal computed tomography imaging in patients with high-risk neuroblastoma.
Satharasinghe K; Trahair TN; Barbaric D; O'Brien TA; Russell SJ; Cohn RJ; Marshall GM; Ziegler DS
J Clin Oncol; 2009 Dec; 27(34):e233-4; author reply e235. PubMed ID: 19884537
[No Abstract] [Full Text] [Related]
8. Radioiodinated meta-iodobenzylguanidine in the diagnosis of childhood neuroblastoma.
Claudiani F; Stimamiglio P; Bertolazzi L; Cabria M; Conte M; Villavecchia GP; Garaventa A; Lanino E; De Bernardi B; Scopinaro G
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):21-4. PubMed ID: 9002744
[TBL] [Abstract][Full Text] [Related]
9. Positive MIBG scanning at the time of relapse in neuroblastoma which was MIBG negative at diagnosis.
Schwarz KB; Driver I; Lewis IJ; Taylor RE
Br J Radiol; 1997 Jan; 70():90-2. PubMed ID: 9059302
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of catecholamine metabolites, mIBG scan, and bone marrow cytology as response markers in stage 4 neuroblastoma.
Hero B; Hunneman DH; Gahr M; Berthold F
Med Pediatr Oncol; 2001 Jan; 36(1):220-3. PubMed ID: 11464889
[TBL] [Abstract][Full Text] [Related]
11. The MIBG super scan.
Giammarile F
Pediatr Radiol; 1998 Jun; 28(6):487. PubMed ID: 9634471
[No Abstract] [Full Text] [Related]
12. I-123 MIBG scan of metastatic neuroblastoma mimicking a bone scan.
Ravizzini G; Pryma DA; Meirelles GS; Divgi CR
Clin Nucl Med; 2006 Sep; 31(9):558-60. PubMed ID: 16921285
[No Abstract] [Full Text] [Related]
13. Exploiting the MIBG-avidity of neuroblastoma for staging and treatment.
Kushner BH; Cheung NK
Pediatr Blood Cancer; 2006 Dec; 47(7):863-4. PubMed ID: 16544298
[No Abstract] [Full Text] [Related]
14. False-negative metaiodobenzylguanidine scintigraphy at diagnosis of neuroblastoma.
Biasotti S; Garaventa A; Villavecchia GP; Cabria M; Nantron M; De Bernardi B
Med Pediatr Oncol; 2000 Aug; 35(2):153-5. PubMed ID: 10918246
[No Abstract] [Full Text] [Related]
15. False-positive MIBG uptake in pneumonia in a patient with stage IV neuroblastoma.
Schindler T; Yu C; Rossleigh M; Pereira J; Cohn R
Clin Nucl Med; 2010 Sep; 35(9):743-5. PubMed ID: 20706060
[TBL] [Abstract][Full Text] [Related]
16. Skeletal assessment in neuroblastoma--the pitfalls of iodine-123-MIBG scans.
Gordon I; Peters AM; Gutman A; Morony S; Dicks-Mireaux C; Pritchard J
J Nucl Med; 1990 Feb; 31(2):129-34. PubMed ID: 2313350
[TBL] [Abstract][Full Text] [Related]
17. Does I-131-MIBG underestimate skeletal disease burden in neuroblastoma?
Barai S; Bandopadhayaya GP; Malhotra A; Agarwal S; Kumar R; Dhanapathi H
J Postgrad Med; 2004; 50(4):257-60; discussion 260-1. PubMed ID: 15623965
[TBL] [Abstract][Full Text] [Related]
18. Nuclear medicine procedures and neuroblastoma in childhood. Their value in the diagnosis, staging and assessment of response to therapy.
Boubaker A; Bischof Delaloye A
Q J Nucl Med; 2003 Mar; 47(1):31-40. PubMed ID: 12714952
[TBL] [Abstract][Full Text] [Related]
19. Correlation of early metastatic response by 123I-metaiodobenzylguanidine scintigraphy with overall response and event-free survival in stage IV neuroblastoma.
Matthay KK; Edeline V; Lumbroso J; Tanguy ML; Asselain B; Zucker JM; Valteau-Couanet D; Hartmann O; Michon J
J Clin Oncol; 2003 Jul; 21(13):2486-91. PubMed ID: 12829667
[TBL] [Abstract][Full Text] [Related]
20. Asymmetric thoracic metaiodobenzylguanidine (MIBG) activity due to prior radiation therapy.
Bai X; Yang H; Zhuang H
Clin Nucl Med; 2015 Jun; 40(6):e338-40. PubMed ID: 25742240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
